The present disclosure relates to biguanide derivatives of formula (I) and their rearrangement products. The present disclosure also relates to the use of these compounds in a method for treating cancer, in particular melanoma.
本公开涉及式(I)的双胍衍
生物及其重排产物。本公开还涉及这些化合物在治疗癌症,特别是
黑色素瘤的方法中的用途。